Pattern Bioscience

📍 Austin, United States🗓 Founded 2016👥 73 employees💰 Last funded Jul 2020
Biotechnology Research🌐 pattern.bio
Website LinkedIn
Tackling a global health threat like antimicrobial resistance is not for the faint of heart, but the experienced and innovative team at Pattern Bioscience is on a mission to do it. Each year, drug-resistant bacterial infections claim more than a million lives globally and cost our healthcare system billions of dollars. Traditional diagnostic methods for bacterial infections remain rooted in slow, cumbersome, decades-old technology that contributes to sub-optimal treatment and the misuse of broad-spectrum antibiotics. The Pattern system is different. We’re developing the world’s only culture-free, rapid diagnostic technology that will reduce the time needed for pathogen identification (ID) and antibiotic susceptibility test (AST) results from days to hours. Our technology combines single-cell analysis of microorganisms with machine learning tools to deliver fast, clinically actionable information. The result? Patients get the right treatment faster, to save lives, prevent side effects and reduce healthcare costs.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Pattern Bioscience?
Pattern Bioscience has 2 investors on record on gritt.io, 2 mid-stage.
When did Pattern Bioscience last raise funding?
The most recent investment in Pattern Bioscience recorded on gritt.io was in July 2020.
When was Pattern Bioscience founded?
Pattern Bioscience was founded in 2016.
What industry is Pattern Bioscience in?
Pattern Bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pattern Bioscience based?
Pattern Bioscience is headquartered in Austin, United States.